Lamotrigine Open Trial in Refractory Epilepsy

Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: J Gordon Millichap (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Pediatric Neurology Briefs Publishers, 1997-10-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis